LungÕ 2026 – Virtual Global Congress on Lung Oncology
ASTRIDE Bridges the Gap: Serplulimab Matches 32% Two-Year Survival in U.S. Patients with Small Cell Lung Cancer
Daniel Malarek and a Wish for Oncology: A Future Where Breakthroughs Reach Every Patient
London Global Cancer Week 2026: Highlights From November 2–4
Expert Discussion at COGC 2026: The Right First Investments in Precision Oncology
BeOne Medicines’ Zanubrutinib Combination Gains FDA Priority Review for First-Line Mantle Cell Lymphoma
Perioperative Ivonescimab Shows Promising Pathological Responses in Resectable NSCLC: Phase II Trial Reports 70.1% MPR and 50.7% pCR
From TAILORx to OPTIMA: Genomic Testing Expands Chemotherapy De-escalation in Higher-Risk HR-Positive Breast Cancer
The Community Practice Connections™: Personalized Approaches in NSCLC: Early Detection, Molecular Testing, and Targeted Therapies activity, provided by Physicians’ Education Resource® (PER®), is available on demand from November 25, 2025, […]
The “Cure to Cancer Survivorship: A New Era of Biomarkers, Interventions, and Care Models” conference will take place on February 6, 2027, at the Loews Atlanta Hotel in Atlanta, Georgia. […]
The 20th Annual New York GU Cancers Congress®, organized by Physicians’ Education Resource® (PER®), will take place on March 13, 2027, at the Conrad New York Downtown in New York […]
